What Researchers Did
Researchers reviewed 20 patients treated over 15 years for osteoradionecrosis of the temporal bone, a serious complication of radiation therapy for head and neck cancers, and proposed a treatment protocol.
What They Found
Patients presented with persistent pain, ear infections, nerve damage, and in severe cases, life-threatening infection spread to the skull base and brain. HBOT was used alongside antibiotics, surgical cleaning, and in advanced cases, major skull-base surgery with tissue reconstruction. Early-stage cases responded to conservative treatment including HBOT, while advanced cases required radical surgery.
What This Means for Canadian Patients
For Canadians who develop bone death in the skull after radiation treatment for throat, ear, or head cancer, HBOT should be considered early, before the condition progresses to a life-threatening stage requiring major surgery. Early access to HBOT may prevent the need for radical reconstructive procedures.
Canadian Relevance
Osteoradionecrosis is an OHIP-covered indication for HBOT in Ontario. Canadian patients with temporal bone osteoradionecrosis following head and neck radiation may be eligible for covered treatment.
Study Limitations
This retrospective 15-year review involves only 20 patients at a single centre, making it difficult to generalize the proposed protocol broadly.